Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 493

1.

Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo.

Bradl M, Misu T, Takahashi T, Watanabe M, Mader S, Reindl M, Adzemovic M, Bauer J, Berger T, Fujihara K, Itoyama Y, Lassmann H.

Ann Neurol. 2009 Nov;66(5):630-43. doi: 10.1002/ana.21837.

PMID:
19937948
2.

Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury.

Marignier R, Nicolle A, Watrin C, Touret M, Cavagna S, Varrin-Doyer M, Cavillon G, Rogemond V, Confavreux C, Honnorat J, Giraudon P.

Brain. 2010 Sep;133(9):2578-91. doi: 10.1093/brain/awq177. Epub 2010 Aug 5.

PMID:
20688809
3.

Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.

Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y.

Brain. 2007 May;130(Pt 5):1224-34. Epub 2007 Apr 2.

PMID:
17405762
4.

Neuromyelitis optica: Passive transfer to rats by human immunoglobulin.

Kinoshita M, Nakatsuji Y, Kimura T, Moriya M, Takata K, Okuno T, Kumanogoh A, Kajiyama K, Yoshikawa H, Sakoda S.

Biochem Biophys Res Commun. 2009 Sep 4;386(4):623-7. doi: 10.1016/j.bbrc.2009.06.085. Epub 2009 Jun 21.

PMID:
19545538
5.

Prediction of neuromyelitis optica attack severity by quantitation of complement-mediated injury to aquaporin-4-expressing cells.

Hinson SR, McKeon A, Fryer JP, Apiwattanakul M, Lennon VA, Pittock SJ.

Arch Neurol. 2009 Sep;66(9):1164-7. doi: 10.1001/archneurol.2009.188.

PMID:
19752309
6.

[Neuromyelitis optica and anti-aquaporin 4 antibody--an overview].

Misu T, Fujihara K, Itoyama Y.

Brain Nerve. 2008 May;60(5):527-37. Review. Japanese.

PMID:
18516975
7.

Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment.

Vincent T, Saikali P, Cayrol R, Roth AD, Bar-Or A, Prat A, Antel JP.

J Immunol. 2008 Oct 15;181(8):5730-7.

8.

Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.

Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, Lennon VA.

Neurology. 2007 Dec 11;69(24):2221-31. Epub 2007 Oct 10.

PMID:
17928579
9.

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.

Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF.

Brain. 2007 May;130(Pt 5):1194-205. Epub 2007 Feb 4.

PMID:
17282996
10.

[Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].

Kira J.

Rinsho Shinkeigaku. 2010 Nov;50(11):788-93. Review. Japanese.

PMID:
21921443
11.

Effector functions of antiaquaporin-4 autoantibodies in neuromyelitis optica.

Cayrol R, Saikali P, Vincent T.

Ann N Y Acad Sci. 2009 Sep;1173:478-86. doi: 10.1111/j.1749-6632.2009.04871.x. Review.

PMID:
19758189
12.

[Neuromyelitis optica and anti-aquaporin 4 antibody--distinct from multiple sclerosis].

Misu T, Takahashi T, Nakashima I, Fujihara K, Itoyama Y.

Rinsho Byori. 2009 Mar;57(3):262-70. Review. Japanese.

PMID:
19363997
13.

Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report.

Misu T, Fujihara K, Nakamura M, Murakami K, Endo M, Konno H, Itoyama Y.

Tohoku J Exp Med. 2006 Jul;209(3):269-75.

14.

[Neuromyelitis optica: a separate disease entity associated with aquaporin-4-antibodies].

Jordan B, Eger K, Kornhuber ME, Zierz S.

Fortschr Neurol Psychiatr. 2008 Jan;76(1):21-7. doi: 10.1055/s-2007-993032. Review. German.

PMID:
18189220
15.

Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica.

Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, Glogowska M, Case D, Antel JP, Owens GP, Gilden D, Nessler S, Stadelmann C, Hemmer B.

Ann Neurol. 2009 Nov;66(5):617-29. doi: 10.1002/ana.21802.

16.

Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.

Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, Ishizu T, Minohara M, Kikuchi H, Mihara F, Ohyagi Y, Kira J.

Brain. 2007 May;130(Pt 5):1206-23. Epub 2007 Apr 17.

PMID:
17439988
17.

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y.

Brain. 2007 May;130(Pt 5):1235-43. Epub 2007 Apr 19.

PMID:
17449477
18.

Pathologic and immunologic profiles of a limited form of neuromyelitis optica with myelitis.

Yanagawa K, Kawachi I, Toyoshima Y, Yokoseki A, Arakawa M, Hasegawa A, Ito T, Kojima N, Koike R, Tanaka K, Kosaka T, Tan CF, Kakita A, Okamoto K, Tsujita M, Sakimura K, Takahashi H, Nishizawa M.

Neurology. 2009 Nov 17;73(20):1628-37. doi: 10.1212/WNL.0b013e3181c1deb9.

PMID:
19917985
19.

Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica.

Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Ishii N, Itoyama Y.

Tohoku J Exp Med. 2006 Dec;210(4):307-13.

20.

Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica.

Saikali P, Cayrol R, Vincent T.

Autoimmun Rev. 2009 Dec;9(2):132-5. doi: 10.1016/j.autrev.2009.04.004. Epub 2009 Apr 21. Review.

PMID:
19389490

Supplemental Content

Support Center